Syneron Medical Ltd. (ELOS) said its third-quarter net loss attributable to the company's shareholders was $5.55 million or $0.20 per share versus a profit of $2.19 million or $0.08 per share last year.
On a non-GAAP basis, excluding stock-based compensation expenses, net loss in the third quarter was $4.81 million or $0.17 per share, compared with a profit of $3.08 million or $0.11 per share in the third quarter of 2008.
Revenues for the third quarter of 2009 were $14.28 million, lower than $28.49 million in the comparable period. On average, 3 analysts polled by Thomson Reuters expected loss per share of $0.15 on revenues of $14.74 million for the quarter. Analysts' estimate typically excludes one-time items.
For comments and feedback: editorial@rttnews.com